Zobrazeno 1 - 10
of 11
pro vyhledávání: '"J Paul Rocchiccioli"'
Autor:
Peter J McCartney, Hany Eteiba, Annette M Maznyczka, Margaret McEntegart, John P Greenwood, Douglas F Muir, Saqib Chowdhary, Anthony H Gershlick, Clare Appleby, James M Cotton, Andrew Wragg, Nick Curzen, Keith G Oldroyd, Mitchell Lindsay, J Paul Rocchiccioli, Aadil Shaukat, Richard Good, Stuart Watkins, Keith Robertson, Christopher Malkin, Lynn Martin, Lynsey Gillespie, Thomas J Ford, Mark C Petrie, Peter W Macfarlane, R Campbell Tait, Paul Welsh, Naveed Sattar, Robin A Weir, Keith A Fox, Ian Ford, Alex McConnachie, Colin Berry
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 7, Iss 5 (2020)
Background: Microvascular obstruction commonly affects patients with acute ST-segment elevation myocardial infarction and is independently associated with adverse outcomes. Objective: To determine whether or not a strategy involving low-dose intracor
Externí odkaz:
https://doaj.org/article/fc208743f26f4d749301a786da2a84da
Autor:
J. Paul Rocchiccioli, Colin Berry, Robin A.P. Weir, James Cotton, Peter McCartney, Alex McConnachie, John P Greenwood, Thomas J. Ford, Christopher J Malkin, Stuart Watkins, Hany Eteiba, Keith G. Oldroyd, Richard Good, Damien Collison, Aadil Shaukat, Lynsey Gillespie, Annette Maznyczka, Stuart Hood, Mitchell Lindsay, Keith Robertson, Margaret McEntegart
Publikováno v:
Circulation. Cardiovascular interventions. 14(2)
Background: The index of microcirculatory resistance (IMR) of the infarct-related artery and left ventricular end-diastolic pressure (LVEDP) are acute, prognostic biomarkers in patients undergoing primary percutaneous coronary intervention. The clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d4d011aa06911eadb2f944ee9ba989
https://pubmed.ncbi.nlm.nih.gov/33591821
https://pubmed.ncbi.nlm.nih.gov/33591821
Autor:
Keith G. Oldroyd, Lynsey Gillespie, Richard Good, Andrew Wragg, Naveed Sattar, Nick Curzen, Keith Robertson, James Cotton, Annette Maznyczka, Mark C. Petrie, J. Paul Rocchiccioli, Anthony H. Gershlick, R. Campbell Tait, Paul Welsh, Peter McCartney, Margaret McEntegart, Hany Eteiba, Alex McConnachie, John P Greenwood, Saqib Chowdhary, Thomas J. Ford, Christopher J Malkin, Ian Ford, Peter W. Macfarlane, Douglas F Muir, Keith A.A. Fox, Lynn Martin, Aadil Shaukat, Colin Berry, Stuart Watkins, Clare Appleby, Robin A.P. Weir, Mitchell Lindsay
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 7, Iss 5 (2020)
Background Microvascular obstruction commonly affects patients with acute ST-segment elevation myocardial infarction and is independently associated with adverse outcomes. Objective To determine whether or not a strategy involving low-dose intracoron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bbf29cec365ee8c44e850cb75e9807e
https://doaj.org/article/fc208743f26f4d749301a786da2a84da
https://doaj.org/article/fc208743f26f4d749301a786da2a84da
Autor:
Thomas J. Ford, Christopher J Malkin, Peter McCartney, Kirsty Wetherall, Alex McConnachie, Mark C. Petrie, John P Greenwood, Robin A.P. Weir, J. Paul Rocchiccioli, Colin J. Petrie, Keith A.A. Fox, Nick Curzen, Nitish Ramparsad, Keith Robertson, James Cotton, Mitchell Lindsay, Anthony H. Gershlick, Douglas F Muir, Lynn Martin, Aadil Shaukat, Annette Maznyczka, Stuart Watkins, Hany Eteiba, Keith G. Oldroyd, Margaret McEntegart, Clare Appleby, Lynsey Gillespie, Ian Ford, Saqib Chowdhary, Richard Good, Colin Berry, Aengus Murphy, Andrew Wragg
Publikováno v:
Circulation: Cardiovascular Interventions. 13
No abstract available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb52eee1dcfc322d18f53d840c5f108
https://doi.org/10.1161/circinterventions.119.008855
https://doi.org/10.1161/circinterventions.119.008855
Autor:
Gavin J. Bryce, Carlene A. Hamilton, Geoffrey Berg, María U. Moreno, David M. Carty, Anna F. Dominiczak, J. Paul Rocchiccioli, Jane A. Dymott, Christian Delles, Ulf Neisius
Publikováno v:
Atherosclerosis
Objective Recent guidelines recommend more aggressive lipid-lowering in secondary prevention protocols. We examined whether this resulted in improved endothelial function. Methods We studied saphenous vein specimens of patients undergoing surgical co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d205574985d082993ab1cab8002d085d
http://europepmc.org/articles/PMC2946556
http://europepmc.org/articles/PMC2946556
Publikováno v:
Progress in Palliative Care. 16:229-240
In this review, the authors outline the management of advanced heart failure and discuss difficulties in the interpretation of the evidence-base, practical problems of drug-based therapy, and future novel strategies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86192de299928d923612493a3d7583ac
https://doi.org/10.1179/096992608x346233
https://doi.org/10.1179/096992608x346233
This chapter addresses the state of knowledge in the evidence-based management of heart failure (HF) with medications. Diuretics were amongst the first therapies to be used in the treatment of HF. Angiotensin-converting enzyme (ACE) inhibitors are co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb142c4fb357b2537badc5a024d62768
https://doi.org/10.1093/acprof:oso/9780198570288.003.0004
https://doi.org/10.1093/acprof:oso/9780198570288.003.0004
Publikováno v:
Heart failure reviews. 15(4)
The diagnosis and management of heart failure remains challenging despite considerable clinical advances in recent decades. With greater understanding of the pathophysiology of this complex syndrome, a large number of candidate biomarkers have emerge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ef956151d5c0428beb13fe63873bfdd
https://pubmed.ncbi.nlm.nih.gov/19051010
https://pubmed.ncbi.nlm.nih.gov/19051010
Publikováno v:
Heart. 101:A12.2-A13
Introduction The Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) trial demonstrated that eplerenone reduces all-cause mortality and death or hospitalisation for cardiovascular events in patients with sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1abd8be80b92f9f64c5d42a534af61aa
https://doi.org/10.1136/heartjnl-2015-308066.22
https://doi.org/10.1136/heartjnl-2015-308066.22
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.